Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-000799

ACURA PHARMACEUTICALS, INC · ACUR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 2, 2018
Accepted (ET)
Jan 3, 2018 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000786947

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Jan 2, 2018M82,774—A144,339D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock Units (2014 Plan)F6,F2,F4,F5—Jan 2, 2018M82,774D——Common Stock82,7740D
Restricted Stock Units (2017 Plan)F6,F2,F4,F7—Jan 2, 2018A66,666A——Common Stock66,66666,666D

Explanation of responses